Inactive Instrument

AESR HEAL Stock

Equities

AEHA

US00809L1061

Dynamic Chart
Aesther Healthcare Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Ocean Biomedical, Aesther Healthcare Acquisition Complete Merger MT
Aesther Healthcare Acquisition Corp.(NasdaqGM:AEHA) dropped from NASDAQ Composite Index CI
Ocean Biomedical, Inc. completed the acquisition of Aesther Healthcare Acquisition Corp. (NasdaqGM : AEHA) from a group of shareholders in a reverse merger transaction. CI
Aesther Healthcare Acquisition, Ocean Biomedical Secure Shareholders Approval for Planned Merger MT
Aesther Healthcare Acquisition Announces Three-Month Extension to Complete Ocean Biomedical Deal MT
Aesther Healthcare Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Aesther Healthcare Acquisition Pays $1.05 Million Fee to Extend Merger Deadline with Ocean Biomedical MT
Aesther Healthcare Acquisition Corp. has Changed its Name to Ocean Biomedical, Inc CI
Aesther Healthcare Acquisition Receives Board Nod to Extend Time Period to Consummate Business Combination MT
Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Discovery of Bispecific Antibodies CI
Aesther Healthcare Acquisition Signs Merger Deal With Ocean Biomedical MT
Ocean Biomedical, Inc. entered into an Agreement and plan of merger to acquire Aesther Healthcare Acquisition Corp. (NasdaqGM : AEHA) from a group of shareholders in a reverse merger transaction for approximately $430 million. CI
United Gear & Assembly, Inc. completed the acquisition of Aesther Healthcare Acquisition Corp. from Aesther Healthcare Sponsor, LLC and others in a reverse merger transaction. CI
Aesther Healthcare Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
More news
Aesther Healthcare Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination. The Company intends to focus on pharmaceutical and medical devices sectors. The Company has not commenced any operations nor generated any revenue.
Sector
-
More about the company